Question 1

What are the potential benefits of using plerixafor in my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma clinical trial (NCT02221492). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other stem cell collection methods?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma clinical trial (NCT02221492). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from the treatments in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma clinical trial (NCT02221492). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma clinical trial (NCT02221492). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I don't respond well to the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma clinical trial (NCT02221492). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks related to my current health conditions that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma clinical trial (NCT02221492). Contact the study team or your healthcare provider for specific answers.

What this study is about